On behalf of the OSCCM Education Committee, I would like to invite you to a virtual Debate on the ANNEXA-I Trial on Thursday August 15th at 1pm. Our expert panel from around the state will be discussing the role of Andexanet alfa in Xa inhibitor-associated ICH. Pease join us for a thoughtful discussion and be prepared with questions!
Free registration required: https://bit.ly/46mRWjG
------------------------------
Bethany Mocas, PharmD, BCCCP
Cleveland Clinic
------------------------------